Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...

In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...

Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...